Malaysia confirmed a new case of mpox, marking a significant development in public health within the country. This case involves a Malaysian man who had not travelled abroad recently, suggesting that the virus is now circulating locally within the community.
The Ministry of Health (MOH) reported this positive identification as the first confirmed mpox infection from the clade II strain, amidst 58 suspected cases recorded throughout the year. Since July 26, 2023, Malaysia has seen a total of ten confirmed cases, all belonging to clade II.
Clade II mpox infections are generally less severe than their clade I counterparts, according to data from the United States’ Centres for Disease Control and Prevention (CDC). Survival rates are notably high; over 99.9 per cent of those infected with clade II recover. In contrast, clade I has a much higher mortality risk, with reports indicating that up to 10 per cent of those infected may succumb to the illness.
The patient in question began experiencing symptoms such as fever, sore throat, and cough on September 11. By September 12, rashes had developed, prompting further medical attention. Health director-general Dr Muhammad Radzi Abu Hassan provided these details in an official statement. Importantly, the patient had no documented travel history outside of Malaysia in the 21 days leading up to the onset of symptoms. Currently, he is in isolation and his condition is stable. The MOH is actively tracing contacts linked to the patient, ensuring their health is monitored rigorously through established standard operating procedures (SOPs).
Dr Radzi’s announcement did not disclose the specific location of the confirmed case for data privacy purpose and to avoid discrimination, however this leaves some uncertainty within the community.
As the global mpox outbreak evolves, it is noteworthy that the predominant strain is clade 1B, which has been rapidly spreading in the Democratic Republic of the Congo (DRC). This alarming situation was significant enough for the World Health Organization (WHO) to declare a public health emergency of international concern on August 14.
In response to this emerging threat, Dr Radzi has urged individuals displaying high-risk symptoms—such as fever, swollen lymph nodes, and rashes or blisters—to seek immediate medical evaluation and treatment at their nearest healthcare facility. The advice extends to avoiding direct contact with individuals suspected or confirmed to have mpox. Maintaining proper hand hygiene, including frequent handwashing or using hand sanitiser, is also strongly recommended.
Healthcare professionals play a crucial role in this public health scenario. They are mandated to report any suspected mpox cases to the nearest district health office (PKD) through an electronic notification system. For any suspected cases, it is essential to collect blister swabs, oral swabs, and blood or serum samples for analysis in laboratories equipped to conduct mpox virus detection tests.
Symptoms associated with mpox are diverse and can include fever, rashes, blisters, or scabs on various parts of the body—particularly on the face, palms, soles of the feet, and genitals. Conjunctivitis may also occur. Transmission of the virus can take place through direct skin-to-skin contact with a rash or scabs from an infected person. Additionally, contact with saliva, respiratory secretions—such as mucus—and bodily fluids or lesions around sensitive areas can facilitate infection.
Dr Radzi noted that the incubation period for mpox ranges between five and 21 days following exposure. This means that individuals can be infectious even before exhibiting any symptoms—starting a day prior to symptom onset and continuing until all scabs have dried up completely. It is worth mentioning that many cases of mpox resolve on their own without requiring specific medical intervention.
As Malaysia navigates this new chapter in its public health landscape, vigilance remains crucial. Authorities are working diligently to monitor and manage potential outbreaks while educating the public about preventive measures. The emergence of local transmission highlights the need for ongoing awareness and responsiveness not only among healthcare providers but also within communities at large.
In light of these recent developments, it becomes imperative for residents to stay informed about mpox symptoms and transmission routes. The government’s proactive stance in tracing contacts and ensuring healthcare access demonstrates a commitment to safeguarding public health.
This case reiterates the importance of community cooperation in combatting infectious diseases. Through collective efforts in maintaining hygiene practices and seeking timely medical care, individuals can contribute significantly to controlling the spread of mpox.
As Malaysia continues to monitor this evolving situation closely, it underscores the necessity for constant vigilance against viral infections that may pose threats to public health now and in the future.
